Celcuity

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Celcuity and other ETFs, options, and stocks.

About CELC

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies.

CEO

Brian F. Sullivan

CEOBrian F. Sullivan

Employees

155

Employees155

Headquarters

Minneapolis, Minnesota

HeadquartersMinneapolis, Minnesota

Founded

2012

Founded2012

Employees

155

Employees155

CELC Key Statistics

Market cap

5.44B

Market cap5.44B

Price-Earnings ratio

-29.82

Price-Earnings ratio-29.82

Dividend yield

—

Dividend yield—

Average volume

866.04K

Average volume866.04K

High today

$114.65

High today$114.65

Low today

$109.20

Low today$109.20

Open price

$109.20

Open price$109.20

Volume

384.39K

Volume384.39K

52 Week high

$120.32

52 Week high$120.32

52 Week low

$7.58

52 Week low$7.58

Stock Snapshot

With a market cap of 5.44B, Celcuity(CELC) trades at $112.47. The stock has a price-to-earnings ratio of -29.82.

On 2026-04-02, Celcuity(CELC) stock moved within a range of $109.20 to $114.65. With shares now at $112.47, the stock is trading +3.0% above its intraday low and -1.9% below the session's peak.

Trading activity shows a volume of 384.39K, compared to an average daily volume of 866.04K.

Over the past 52 weeks, Celcuity(CELC) stock has traded between a high of $120.32 and a low of $7.58.

CELC News

Simply Wall St 1d

Is It Too Late To Consider Celcuity After Its Strong Multi‑Year Share Price Run?

Investors may be wondering if Celcuity at around US$114 a share is still offering value, or if most of the upside has already been priced in. The stock has del...

Simply Wall St 3d

Did Gedatolisib’s Priority Review and Commercial Build-Out Just Shift Celcuity's Investment Narrative?

In March 2026, Celcuity reported that its full-year 2025 net loss widened to US$177.04 million, or US$3.79 per share, while management emphasized the FDA’s earl...

Simply Wall St 6d

Celcuity’s Priority Review Puts Gedatolisib And Investor Trade Offs In Focus

Celcuity (NasdaqCM:CELC) received FDA Priority Review for its New Drug Application for gedatolisib in advanced breast cancer. The Priority Review follows stron...

Analyst ratings

91%

of 11 ratings

Buy

90.9%

Hold

9.1%

Sell

More CELC News

TipRanks 7d

Celcuity’s Earnings Call: Big Data, Bigger Ambitions

Celcuity Inc. ((CELC)) has held its Q4 earnings call. Read on for the main highlights of the call. Claim 30% Off TipRanks Premium Unlock hedge fund-level data a...

People also own

Based on the portfolios of people who own CELC. This list is generated using Robinhood data, and it’s not a recommendation.

D-Wave Quantum

Micron Technology

Taiwan Semiconductor Manu…

Applied Digital

Rigetti Computing

Broadcom

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.